Cargando…

Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes

BACKGROUND: Gut microbiota plays an important role in the pathogenesis of immune-mediated diseases. However, the complex pathogenesis of Henoch-Schonlein Purpura (HSP) remains elusive. This study aimed to characterize the gut microbiota in HSP patients and explore the potential association between g...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuanzhen, Xia, Guizhi, Nie, Xiaojing, Zeng, Yugui, Chen, Yi, Qian, Yifang, Chen, Guangming, Huang, Jun, Wang, Chengfeng, Zhang, Chuanyin, Huang, Xiaoli, Yang, Yuen, Qiu, Xiaojian, Yang, Fang, Chen, Jie, Hu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281929/
https://www.ncbi.nlm.nih.gov/pubmed/34277463
http://dx.doi.org/10.3389/fcimb.2021.641997
_version_ 1783722915269705728
author Zhang, Yuanzhen
Xia, Guizhi
Nie, Xiaojing
Zeng, Yugui
Chen, Yi
Qian, Yifang
Chen, Guangming
Huang, Jun
Wang, Chengfeng
Zhang, Chuanyin
Huang, Xiaoli
Yang, Yuen
Qiu, Xiaojian
Yang, Fang
Chen, Jie
Hu, Jun
author_facet Zhang, Yuanzhen
Xia, Guizhi
Nie, Xiaojing
Zeng, Yugui
Chen, Yi
Qian, Yifang
Chen, Guangming
Huang, Jun
Wang, Chengfeng
Zhang, Chuanyin
Huang, Xiaoli
Yang, Yuen
Qiu, Xiaojian
Yang, Fang
Chen, Jie
Hu, Jun
author_sort Zhang, Yuanzhen
collection PubMed
description BACKGROUND: Gut microbiota plays an important role in the pathogenesis of immune-mediated diseases. However, the complex pathogenesis of Henoch-Schonlein Purpura (HSP) remains elusive. This study aimed to characterize the gut microbiota in HSP patients and explore the potential association between gut microbiota composition and phenotypic changes in HSP. METHODS: 16SrRNA gene sequencing and bioinformatic analyses were performed using total DNA extracted from the fecal microbiota of 34 children with HSP, including 18 primary cases, 16 recurrent cases, and 23 healthy children. RESULTS: The diversity indexes showed significant differences in the microbial community among the primary HSP groups, the recurrent HSP group and healthy controls. The abundance of Escherichia-Shigella in the recurrent HSP group was significantly higher than that in the primary HSP group, and the constructed ROC curve had an AUC value of 0.750. According to the Spearman correlation analysis, the abundance of Bacteroides was positively associated with the serum IgG level in children with HSP, while the abundance of Lachnoclostridium was negatively correlated with the complement component 3 (C3). The diversity indexes of gut microbiota in the HSP group with abdominal symptoms were higher than those in the HSP group without GI involvement, and also higher than those in the healthy control group. In the HSP group with GI involvement, the abundance of Faecalibacterium was decreased, while the abundance of Streptococcus and Fusobacteria was increased, compared to the HSP group without GI involvement. CONCLUSIONS: The gut microbiota of children with HSP was different from that of healthy children. The genus Escherichia-Shigella has a diagnostic value for HSP recurrence. Bacteroides and Lachnoclostridium may affect IgG and complement C3 levels in children with HSP. Abdominal symptoms in HSP children were related to gut microbiota (Streptococcus and butyric acid-producing bacteria).
format Online
Article
Text
id pubmed-8281929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82819292021-07-16 Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes Zhang, Yuanzhen Xia, Guizhi Nie, Xiaojing Zeng, Yugui Chen, Yi Qian, Yifang Chen, Guangming Huang, Jun Wang, Chengfeng Zhang, Chuanyin Huang, Xiaoli Yang, Yuen Qiu, Xiaojian Yang, Fang Chen, Jie Hu, Jun Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Gut microbiota plays an important role in the pathogenesis of immune-mediated diseases. However, the complex pathogenesis of Henoch-Schonlein Purpura (HSP) remains elusive. This study aimed to characterize the gut microbiota in HSP patients and explore the potential association between gut microbiota composition and phenotypic changes in HSP. METHODS: 16SrRNA gene sequencing and bioinformatic analyses were performed using total DNA extracted from the fecal microbiota of 34 children with HSP, including 18 primary cases, 16 recurrent cases, and 23 healthy children. RESULTS: The diversity indexes showed significant differences in the microbial community among the primary HSP groups, the recurrent HSP group and healthy controls. The abundance of Escherichia-Shigella in the recurrent HSP group was significantly higher than that in the primary HSP group, and the constructed ROC curve had an AUC value of 0.750. According to the Spearman correlation analysis, the abundance of Bacteroides was positively associated with the serum IgG level in children with HSP, while the abundance of Lachnoclostridium was negatively correlated with the complement component 3 (C3). The diversity indexes of gut microbiota in the HSP group with abdominal symptoms were higher than those in the HSP group without GI involvement, and also higher than those in the healthy control group. In the HSP group with GI involvement, the abundance of Faecalibacterium was decreased, while the abundance of Streptococcus and Fusobacteria was increased, compared to the HSP group without GI involvement. CONCLUSIONS: The gut microbiota of children with HSP was different from that of healthy children. The genus Escherichia-Shigella has a diagnostic value for HSP recurrence. Bacteroides and Lachnoclostridium may affect IgG and complement C3 levels in children with HSP. Abdominal symptoms in HSP children were related to gut microbiota (Streptococcus and butyric acid-producing bacteria). Frontiers Media S.A. 2021-07-01 /pmc/articles/PMC8281929/ /pubmed/34277463 http://dx.doi.org/10.3389/fcimb.2021.641997 Text en Copyright © 2021 Zhang, Xia, Nie, Zeng, Chen, Qian, Chen, Huang, Wang, Zhang, Huang, Yang, Qiu, Yang, Chen and Hu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Zhang, Yuanzhen
Xia, Guizhi
Nie, Xiaojing
Zeng, Yugui
Chen, Yi
Qian, Yifang
Chen, Guangming
Huang, Jun
Wang, Chengfeng
Zhang, Chuanyin
Huang, Xiaoli
Yang, Yuen
Qiu, Xiaojian
Yang, Fang
Chen, Jie
Hu, Jun
Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title_full Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title_fullStr Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title_full_unstemmed Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title_short Differences in Manifestations and Gut Microbiota Composition Between Patients With Different Henoch-Schonlein Purpura Phenotypes
title_sort differences in manifestations and gut microbiota composition between patients with different henoch-schonlein purpura phenotypes
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281929/
https://www.ncbi.nlm.nih.gov/pubmed/34277463
http://dx.doi.org/10.3389/fcimb.2021.641997
work_keys_str_mv AT zhangyuanzhen differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT xiaguizhi differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT niexiaojing differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT zengyugui differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT chenyi differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT qianyifang differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT chenguangming differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT huangjun differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT wangchengfeng differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT zhangchuanyin differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT huangxiaoli differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT yangyuen differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT qiuxiaojian differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT yangfang differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT chenjie differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes
AT hujun differencesinmanifestationsandgutmicrobiotacompositionbetweenpatientswithdifferenthenochschonleinpurpuraphenotypes